Your browser doesn't support javascript.
loading
Open-label trial of immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults ≥ 50 years of age in Mexico.
Tinoco, Juan Carlos; Juergens, Christine; Ruiz Palacios, Guillermo M; Vazquez-Narvaez, Jorge; Enkerlin-Pauwells, Hermann Leo; Sundaraiyer, Vani; Pathirana, Sudam; Kalinina, Elena; Gruber, William C; Scott, Daniel A; Schmoele-Thoma, Beate.
Afiliação
  • Tinoco JC; Hospital General de Durango, Durango, Mexico jctinoco@prodigy.net.mx.
  • Juergens C; Pfizer Pharma GmbH, Berlin, Germany.
  • Ruiz Palacios GM; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Vazquez-Narvaez J; Star Médica, Michoacan, Mexico.
  • Enkerlin-Pauwells HL; Mexico Centre for Clinical Research, Mexico City, Mexico.
  • Sundaraiyer V; inVentiv Health Clinical, LLC, Princeton, New Jersey, USA.
  • Pathirana S; Pfizer Inc., Pearl River, New York, USA.
  • Kalinina E; Pfizer Inc., Pearl River, New York, USA.
  • Gruber WC; Pfizer Inc., Pearl River, New York, USA.
  • Scott DA; Pfizer Inc., Pearl River, New York, USA.
  • Schmoele-Thoma B; Pfizer Pharma GmbH, Berlin, Germany.
Clin Vaccine Immunol ; 22(2): 185-92, 2015 Feb.
Article em En | MEDLINE | ID: mdl-25499011

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Pneumocócicas / Anticorpos Antibacterianos Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Pneumocócicas / Anticorpos Antibacterianos Idioma: En Ano de publicação: 2015 Tipo de documento: Article